US court upholds $142m Pfizer Neurontin verdict, reverses other rulings
This article was originally published in Scrip
Executive Summary
A US appellate court upheld a $142 million verdict against Pfizer related to the past marketing of its epilepsy pill Neurontin. Perhaps more importantly, the major drug maker faces additional lawsuits from other insurers after rulings made by the court.